4.5 Article

Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis

Journal

CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 180, Issue 2, Pages 201-206

Publisher

WILEY
DOI: 10.1111/cei.12568

Keywords

ankylosing spondylitis; HLA-B27; KIR; susceptibility

Categories

Funding

  1. Fondecyt [11130198]

Ask authors/readers for more resources

The aim of this study was to analyse the association of specific killer cell immunoglobulin-like receptors (KIR) genes and haplotypes with susceptibility to ankylosing spondylitis (AS) and its different clinical manifestations in a Spanish population. The presence or absence of all KIR genes was studied for their association with AS. A total of 176 patients with AS and 435 healthy control subjects were selected for this study based on clinical criteria. The commercial KIR-sequence-specific oligonucleotides (SSO) typing kit was used to investigate KIR typing. Frequencies of KIR2DS1 and KIR3DS1 genes were increased significantly in patients compared with healthy controls [528 versus 382%, P-Bonf < 001, odds ratio (OR)=181 (128-259); 517 versus 375%, P-Bonf < 001, OR=179 (125-254)]. Moreover, the frequency of activating genotypes in the AS patient group was significantly higher than in the healthy control group (P<005). KIR2DS1 and KIR3DS1, in addition to human leucocyte antigen (HLA)-B27, may play an important role in the pathogenesis of AS. However, we show that the contribution of the KIR genes to AS susceptibility extends beyond the association with individual KIRs, with an imbalance between activating and inhibitory KIR genes seeming to influence the susceptibility to AS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain

Ennio Lubrano, Pablo Fanlo Mazas, Jurgen Freiwald, Karsten Kruger, Ignazio Grattagliano, Erich Mur, Ruben Queiro Silva, Guillermo Rodriguez Maruri, Luis Sequeira de Medeiros

Summary: This Delphi consensus recognizes the role of heat therapy mostly in chronic musculoskeletal pain and highlights the need for stronger scientific evidence to regulate the use of this therapy in clinical practice.

PAIN AND THERAPY (2023)

Review Rheumatology

Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Ennio Lubrano, Jon Chan, Ruben Queiro-Silva, Alberto Cauli, Niti Goel, Denis Poddubnyy, Peter Nash, Dafna D. Gladman

Summary: Objective. The objective of this study was to identify and evaluate the efficacy of therapeutic interventions for treatment of axial disease in PsA. Methods. This systematic review updated the treatment recommendations for axial PsA. Results. The literature review revealed that new biologic and targeted synthetic disease-modifying antirheumatic drug classes could be considered for the treatment of axial PsA. Conclusion. Further studies are needed for a better understanding of the treatment of axial PsA.

JOURNAL OF RHEUMATOLOGY (2023)

Article Oncology

Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study

Oscar Rapado-Gonzalez, Jenifer Brea-Iglesias, Aitor Rodriguez-Casanova, Aida Bao-Caamano, Jose-Luis Lopez-Cedrun, Gabriel Triana-Martinez, Roberto Diaz-Pena, Maria Arminda Santos, Rafael Lopez-Lopez, Laura Muinelo-Romay, Monica Martinez-Fernandez, Angel Diaz-Lagares, Maria Mercedes Suarez-Cunqueiro

Summary: This study examines the use of the TST170 panel for detecting somatic mutations in tumor and cfDNA of HNSCC patients. The results demonstrate the potential of a single assay for consistent detection of mutations in both tissue and plasma.

CANCER MEDICINE (2023)

Article Medicine, General & Internal

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning

Ruben Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye S. Park, Jose A. Pinto Tasende, Juan J. Bethencourt Baute, Beatriz Joven Ibanez, Elide Toniolo, Julio Ramirez, Nuria Montero, Cristina Pruenza Garcia-Hinojosa, Ana Serrano Garcia

Summary: This study aimed to identify characteristics predicting moderate-to-high disease activity in recent-onset psoriatic arthritis (PsA). They conducted a multicenter observational prospective study and found that PsAID score, tender joint count, level of physical activity, and sex were predictors of moderate-to-high activity.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience

Ignacio Brana, Estefania Pardo, Stefanie Burger, Pablo Gonzalez del Pozo, Mercedes Alperi, Ruben Queiro

Summary: This study aimed to analyze the retention rate and safety of IXE in patients with PsA in routine clinical practice. The results showed that the retention rate of IXE was high in PsA patients and was consistently good regardless of age, gender, metabolic comorbidities, smoking status, or prior number of biologic therapies.

JOURNAL OF CLINICAL MEDICINE (2023)

Editorial Material Agriculture, Dairy & Animal Science

Assessing the Trophic Impact of Bleaching: The Model Pair Berghia stephanieae/Exaiptasia diaphana

Ruben X. G. Silva, Diana Madeira, Paulo Cartaxana, Ricardo Calado

Summary: Climate change-induced bleaching events have become increasingly common in coral reefs. While direct impacts have received attention, the indirect impacts, such as trophic interactions, have been largely overlooked. To address this research gap, the model predator-prey pair of Berghia stephanieae and Exaiptasia diaphana is advocated for studying the trophic effects of bleaching. These organisms are already used in other research fields, allowing for the utilization of existing knowledge on their physiology and culture protocols. The use of this model pair can help unravel the long-term prevalence of trophic effects in coral reef communities.

ANIMALS (2023)

Article Rheumatology

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

Stefan Siebert, Frank Behrens, Ennio Lubrano, Nicolas Martin, Mohamed Sharaf, Christine Contre, Elke Theander, Ruben Queiro, Miriam Zimmermann, Laure Gossec

Summary: This study aims to collect data on the long-term clinical practice of using guselkumab or interleukin-17 inhibitors for the treatment of PsA to understand drug persistence, effectiveness, and long-term safety. Data will be collected through electronic patient-reported outcomes and physician-completed assessments, along with safety data. The study will last for 36 months with an additional 24-week observation period.

RHEUMATOLOGY AND THERAPY (2023)

Article Rheumatology

EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Annamaria Iagnocco, Paolo Gisondi, Peter Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Nemanja S. Damjanov, Maarten de Wit, Enzo Errichetti, Helena Marzo-Ortega, Mikhail Protopopov, Lluis Puig, Ruben Queiro, Piero Ruscitti, Laura Savage, Georg Schett, Stefan Siebert, Tanja A. Stamm, Paul Studenic, Ilaria Tinazzi, Filip E. Van den Bosch, Annette van der Helm-van Mil, Abdulla Watad, Josef S. Smolen, Dennis G. McGonagle

Summary: This study proposes EULAR guidelines for the early diagnosis of psoriatic arthritis (PsA) by conducting research on multiple patients. It also establishes standardized operating procedures for clinical practice and trials, providing guidance and consensus in the field of prevention and interception of PsA for psoriasis patients.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Pathology

Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients

Patricia Mondelo-Macia, Ramon Manuel Lago-Leston, Aitor Rodriguez-Casanova, Alicia Abalo, Angel Diaz-Lagares, Jorge Garcia-Gonzalez, Luis Leon-Mateos, Roberto Diaz-Pena, Laura Muinelo-Romay

PATHOLOGY (2023)

Article Rheumatology

Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index

Sara Alonso, Isla Morante, Ignacio Brana, Ruben Queiro

Summary: This study compared the factors associated with sleep problems in psoriatic arthritis (PsA) and axial SpA (axSpA). The results showed that a considerable proportion of patients in both populations reported sleep problems. Additionally, sleep quality was associated with factors such as disease activity and inflammation severity in both populations.

REUMATOLOGIA CLINICA (2023)

Editorial Material Biotechnology & Applied Microbiology

Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?

Marta Loredo, Ignacio Brana, Ruben Queiro

EXPERT OPINION ON BIOLOGICAL THERAPY (2023)

Review Immunology

Managing psoriatic arthritis in different clinical scenarios

Ruben Queiro, Marta Loredo, Ignacio Brana, Estefania Pardo, Sara Alonso, Mercedes Alperi

Summary: Psoriatic arthritis (PsA), a chronic immune-mediated disease, significantly impairs patients' physical function and quality of life. Managing PsA is challenging due to its complex clinical features and comorbidities. This article reviews the current understanding of PsA and available pharmacological options, providing expert opinion on treatment strategies considering the disease domain and comorbidities.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Immunology

HLA alleles: important pieces to the COVID-19 puzzle

Patricia Castro-Santos, Angel Carracedo, Roberto Diaz-Pena

Summary: The recent study in Nature by Augusto et al. reveals a strong association between HLA-B*15:01 and asymptomatic COVID-19, making an important contribution to genetics in COVID-19 research.

TRENDS IN IMMUNOLOGY (2023)

Article Cell Biology

HLA-A11:01 and HLA-C04:01 are associated with severe COVID-19

Patricia Castro-Santos, Augusto Rojas-Martinez, Jose A. Riancho, Pablo Lapunzina, Carlos Flores, Angel Carracedo, Roberto Diaz-Pena, Scourge Cohort Group

Summary: We investigated the relationship between HLA polymorphisms and susceptibility to SARS-CoV-2 infection and disease severity. Genotyping data from 9373 COVID-19-positive cases and 5943 population controls were analyzed. The study found associations between HLA-B*14:02 and HLA-C*08:02 alleles with a lower risk of COVID-19 infection, and HLA-A*11:01 and HLA-C*04:01 alleles with disease severity.
No Data Available